A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel- Group Study, Comparing Tretinoin Cream, 0.025% (Aleor Dermaceuticals Limited, India.) to Retin-A® (Tretinoin)Cream, 0.025% (Bausch Health US, LLC., USA) And Both Active Treatments to A Placebo Control in The Treatment of Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel- Group Study, Comparing Tretinoin Cream, 0.1% (Aleor Dermaceuticals Limited, India.) to Retin-A�® (Tretinoin) Cream, 0.1% (Bausch Health US, LlC., USA) And Both Active Treatments to A Placebo Control in The Treatment of Acne Vulgaris
A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Group Study, Comparing Adapalene Gel 0.3% To Differin® Gel 0.3% And Both Active Treatments To A Placebo Control In The Treatment Of Acne Vulgaris
To evaluate the therapeutic equivalence and safety of Adapalene Gel 0.3% (Aleor Dermaceuticals Limited, India) and Differin® (Adapalene) Gel 0.3% (Galderma Laboratories, LP USA) in the treatment of acne vulgaris.
100 Clinical Results associated with Aleor Dermaceuticals Ltd.
0 Patents (Medical) associated with Aleor Dermaceuticals Ltd.
100 Deals associated with Aleor Dermaceuticals Ltd.
100 Translational Medicine associated with Aleor Dermaceuticals Ltd.